Invenomic Capital Management’s BILL Holdings BILL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.9M Sell
908,775
-124,521
-12% -$4.59M 1.96% 13
2026
Q1
$39.6M Buy
1,033,296
+324,384
+46% +$14.5M 1.82% 12
2025
Q4
$38.7M Buy
708,912
+68,990
+11% +$3.54M 1.8% 13
2025
Q3
$33.9M Sell
639,922
-4,640
-0.7% -$215K 1.64% 15
2025
Q2
$29.8M Buy
644,562
+470,351
+270% +$20.8M 1.69% 15
2025
Q1
$7.99M Buy
174,211
+151,413
+664% +$10.2M 0.4% 85
2024
Q4
$1.93M Sell
22,798
-264,447
-92% -$19.7M 0.09% 148
2024
Q3
$15.2M Buy
287,245
+192,776
+204% +$9.93M 0.83% 40
2024
Q2
$4.97M Buy
+94,469
New +$5.35M 0.24% 104

Other funds holding BILL

Invenomic Capital Management's BILL Position: Q2 2026 in Review

Invenomic Capital Management reduced its BILL Holdings (BILL) stake by 12% in Q2 2026, selling an estimated $4.59M and leaving 908,775 shares worth $32.9M. The position accounts for 1.96% of the portfolio, ranked #13.

Invenomic Capital Management first reported a position in BILL in Q2 2024 and has held it in 9 quarters since. The position peaked at $39.6M in Q1 2026. 340 funds tracked by Wall St. Rank hold BILL as of Q2 2026.

  • Invenomic Capital Management held 908,775 shares of BILL Holdings worth $32.9M as of Q2 2026.
  • Invenomic Capital Management sold 124,521 BILL Holdings shares in Q2 2026, an estimated $4.59M.
  • BILL Holdings made up 1.96% of Invenomic Capital Management's portfolio in Q2 2026, its #13 holding.
  • Invenomic Capital Management first reported a position in BILL Holdings in Q2 2024 and has held it in 9 quarters since.
  • Invenomic Capital Management's BILL Holdings position peaked at $39.6M in Q1 2026.
  • 340 funds tracked by Wall St. Rank held BILL Holdings as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.